WIlda Nurhikmah, Yeyet Cahyati, Jessie Sofia Pamudji

Judul	:	Sci. Pharm
Abstrak	:	Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) that is widely used for the treatment of mild-to-moderate pain. Mefenamic acid belongs to the Biopharmaceutical Classification System (BCS) class II drug which has lower water solubility but high permeability. There are two different compendial methods available for dissolution tests of mefenamic acid solid dosage forms, i.e. methods of United States Pharmacopeia 37 (USP) and Pharmacopoeia of the People’s Republic of China 2010 (PPRC). Indonesian Pharmacopeia V ed. (FI) adopted the USP method. On the other hand, many researches focused on the use of a ‘biorelevant’ medium to develop the dissolution test method. The aim of this research was to study the dissolution profile of mefenamic acid from its solid dosage forms (caplet and capsule) available in the Indonesian market with three different dissolution medium: USP, PPRC, and biorelevant fasted simulated small intestinal fluid (FaSSIF) media. The tested products consisted of the innovator’s product (available only in caplet dosage form, FN caplet) and generic products (available as caplet and capsule). The dissolution test of the drug products in all dissolution media was performed in 900 mL of medium using apparatus II (paddle) at a temperature of 37°C and rotation speed of 75 rpm, except for the capsule product and for USP medium, both of which tests were done using apparatus I (basket) with rotation speed of 100 rpm. The solubility test of mefenamic acid was carried out in all media at temperature of 37°C. The result obtained from the solubility test showed that the the highest solubility of mefenamic acid was obtained in USP medium (approximately 2 mg/mL), followed by PPRC medium (about 0.5 mg/mL), and FaSSIF medium (approximately 0.06 mg/ml). In the dissolution test, percentage of drug dissolved in in the USP and PPRC media after 45 min for all products reached more than 75%, except for the PN caplet in USP medium which reached only about 44%. Meanwhile, in the biorelevant medium, the percentage of drug dissolved for all products did not exceed 16%. In all dissolution media, the capsule dosage form achieved the highest dissolution rate. Keywords: Mefenamic acid; Dissolution Testing; Indonesian Pharmacopoeia; United States Pharmacopoeia; Pharmacopoeia of the People’s Republic of China; Biorelevant medium
Tahun	:	2023	Media Publikasi	:	Jurnal Internasional
Kategori	:	Jurnal	No/Vol/Tahun	:	Sci. Pharm. 84(1), 181-190; https://doi.org/10.3797/scipharm.ISP.2015.09 / 84(1) / 2016
ISSN/ISBN	:	doi.org/10.3797/scipharm.ISP.2015.09
PTN/S	:	Institut Teknologi Bandung	Program Studi	:	FARMASI
Bibliography	:	Sweetman SC. Martindale The Complete Drug Reference. London: Pharmaceutical Press, 2009: 80. [2] Modi SV, Patel NJ. Development and evaluation of self emulsifying drug delivery of a poorly water soluble NSAID. World J Pharm Pharm Sci. 2015; 4: 462–479. [3] Council of Experts and Its Expert Committees. United States Pharmacopeia 37. Rockville: United States Pharmacopoeial Convention, 2014: 3672–3673. [4] The State Pharmacopoeia Comission of Peoples’ Republic of China. Pharmacopoeia of the Peoples’ Republic of China. Beijing: Chemical Industry Press, 2010: 748–749. [5] Panitia Farmakope Indonesia V. Farmakope Indonesia V. Jakarta: Kementrian Kesehatan Republik Indonesia, 2014. [6] Galia E, Nicolaides E, Reppas C, Dressman JB. New Media Discriminate Dissolution Properties of Poorly Soluble Drug. Pharm Res.1996; 13: S262–S269. [7] Jantratid E, Janssen N, Reppas C, Dressman JB. Dissolution Media Simulating Condition in the Proximal Human Gastrointestinal Tract : An Update. Pharm Res. 2008; 25: 1663–1676. http://dx.doi.org/10.1007/s11095-008-9569-4 [8] Galia E, Nicolaides E, Horter D, Lobenberg R, Reppas C, Dressman JB. Evaluation of Various Dissolution Media for Predicting in vivo Performance of Class I and II Drugs. Pharm Res.1998; 15: 698–705. http://dx.doi.org/10.1023/A:1011910801212 190 W. Nurhikmah, Y. C. Sumirtapura, and J. S. Pamudji: Sci Pharm. 2016; 84: 181–190 [9] Patil PB, Gupta VRM, Udupi RH, Srikanth K, Prasad BSG. Development of dissolution medium for poorly water soluble drug mefenamic acid. Res J Pharm Biol Chem Sci. 2010; 1: 544–549. [10] Swathi CH, Subrahmanyam CVS, Kedarnath SA, Sathesh Babu PR. Solubilization of mefenamic acid. Int J Pharm Tech. 2011; 3: 3267–3276 [11] Schaich M, Kloefer B, Leigh M. Dissolution Test Results Showing Biorelevant Media made from SIF Powder FaSSIF-V2 are the Same as Media Prepared using Methylene Chloride. Biorelevan.com, 8th March 2013 [12] Anumolu PD, Sunitha Gurrala S, Yeradesi VR, Puvvadi SBR, ChavaliSVS. Development of Dissolution Test Method for Drotaverine Hydrochloride/Mefenamic Acid Combination Using Derivative Spectrophotometry. Tropical J Pharm Res. 2013; 12: 227–232. http://dx.doi.org/10.4314/tjpr.v12i2.15 [13] Park SH, Choi HK. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs. Int J Pharm. 2006; 321: 35–41. http://dx.doi.org/10.1016/j.ijpharm.2006.05.004
URL	:	https://www.mdpi.com/2218-0532/84/1/181